{"schema_version":"secwatch.filing_event.v1","accession":"0001171520-22-000183","form_type":"8-K","ticker":"CLPT","cik":"0001285550","company_name":"ClearPoint Neuro, Inc.","filed_at":"2022-03-01T23:59:59+00:00","discovered_at":"2026-05-14T18:04:05.781544+00:00","generated_at":"2026-06-27T02:48:52.902153+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"ClearPoint Neuro reports Q4 revenue $4.3M (+15%) and record 2021 revenue $16.3M (+27%)","bullets":["Q4 2021 revenue $4.3M (+15% YoY); full-year revenue $16.3M (+27% YoY), seventh consecutive year of growth.","Biologics & drug delivery revenue $6.8M in 2021 (+31% YoY); supported 929 cases despite COVID.","Cash and equivalents $54.1M at year-end, up from $20.1M, aided by Feb 2021 public offering raising ~$46.8M net.","Operating expenses increased to $24.7M (2021) from $15.3M (2020) due to headcount and R&D investments.","2022 revenue guidance reaffirmed at $20-22M; progress on pillars including FDA clearance for Array and BCI collab."],"urls":{"canonical":"https://secwatch.observer/filing/0001171520-22-000183","json":"https://secwatch.observer/filing/0001171520-22-000183.json","markdown":"https://secwatch.observer/filing/0001171520-22-000183.md","text":"https://secwatch.observer/filing/0001171520-22-000183.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1285550/000117152022000183/0001171520-22-000183-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1285550/000117152022000183/eps10120.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T02:48:52.902153+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}